NCT02182167View on ClinicalTrials.gov

A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced Hepatitis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Drug-Induced Liver Injury
Interventions
DRUG

IV N-acetylcysteine (NAC)

DRUG

Water

Trial Locations (2)

7925

Groote Schuur Hospital, Cape Town

8005

New Somerset Hospital, Cape Town

All Listed Sponsors
collaborator

Medical Research Council, South Africa

OTHER

lead

University of Cape Town

OTHER

NCT02182167 - A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced Hepatitis | Biotech Hunter | Biotech Hunter